Skip to main navigation Skip to search Skip to main content

Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer

  • Xu Guo
  • , Zhenyu Liu
  • , Caixia Sun
  • , Lei Zhang
  • , Ying Wang
  • , Ziyao Li
  • , Jiaxin Shi
  • , Tong Wu
  • , Hao Cui
  • , Jing Zhang
  • , Jie Tian*
  • , Jiawei Tian*
  • *Corresponding author for this work
  • Department of Ultrasound
  • The Second Affiliated Hospital of Harbin Medical University
  • CAS - Institute of Automation
  • School of Artificial Intelligence
  • University of Chinese Academy of Sciences
  • School of Engineering Medicine
  • Beihang University
  • Department of General Surgery
  • Hebei Medical University
  • Department of MRI Diagnosis
  • School of Life Science and Technology, Xidian University

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Completion axillary lymph node dissection is overtreatment for patients with sentinel lymph node (SLN) metastasis in whom the metastatic risk of residual non-SLN (NSLN) is low. However, the National Comprehensive Cancer Network panel posits that none of the previous studies has successfully identified such subset patients. Here, we develop a multicentre deep learning radiomics of ultrasonography model (DLRU) to predict the risk of SLN and NSLN metastasis. Methods: In total, 937 eligible breast cancer patients with ultrasound images were enrolled from two hospitals as the training set (n = 542) and independent test set (n = 395) respectively. Using the images, we developed and validated a prediction model combined with deep learning radiomics and axillary ultrasound to sequentially identify the metastatic risk of SLN and NSLN, thereby, classifying patients to relevant axillary management groups. Findings: In the test set, the DLRU yields the best performance in identifying patients with metastatic disease in SLNs (sensitivity=98.4%, 95% CI 96.6–100) and NSLNs (sensitivity=98.4%, 95% CI 95.6–99.9). The DLRU also accurately stratifies patients without metastasis in SLN or NSLN into the corresponding low-risk (LR)-SLN and high-risk (HR)-SLN&LR-NSLN category with the negative predictive value of 97% (95% CI 94.2–100) and 91.7% (95% CI 88.8–97.9), respectively. Moreover, compared with the current clinical management, DLRU appropriately assigned 51% (39.6%/77.4%) of overtreated patients in the entire study cohort into the LR group, perhaps avoiding overtreatment. Interpretation: The performance of the DLRU indicates that it may offer a simple preoperative tool to promote personalized axillary management of breast cancer. Funding: The National Nature Science Foundation of China; The National Outstanding Youth Science Fund Project of National Natural Science Foundation of China; The Scientific research project of Heilongjiang Health Committee; The Postgraduate Research &Practice Innovation Program of Harbin Medical University.

Original languageEnglish
Article number103018
JournalEBioMedicine
Volume60
DOIs
StatePublished - Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Axillary management
  • Deep learning radiomics
  • NSLN metastasis in the axilla
  • Primary breast cancer
  • Ultrasonography

Fingerprint

Dive into the research topics of 'Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer'. Together they form a unique fingerprint.

Cite this